Frequent association of thrombophilia in cerebral venous sinus thrombosis

International Journal of Hematology

Volumn 95, Issue 3, 2012, Pages 257-262

  Ikejiri, Makoto ^a   Yamada, Norikazu ^a   Nakatani, Kaname ^a   Shindo, Akihiro ^a   Ii, Yuichiro ^a   Matsumoto, Takeshi ^a   Nobori, Tsutomu ^a   Tomimoto, Hidekazu ^a   Abe, Yasunori ^a   Wada, Hideo ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Antithrombin; Cerebral venous sinus thrombosis (CVST); Protein C; Protein S; Thrombophilia

Indexed keywords

ALANINE; ANTITHROMBIN; GLYCINE; PROTEIN C; PROTEIN S; WARFARIN;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ANTITHROMBIN DEFICIENCY; ARTICLE; CEREBRAL SINUS THROMBOSIS; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; MUTANT; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; THROMBOPHILIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTITHROMBIN III DEFICIENCY; CELL LINE; CERCOPITHECUS AETHIOPS; CRANIAL SINUSES; CRICETINAE; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; PEDIGREE; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; THROMBOPHILIA; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 84862980907     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-012-1006-0     Document Type: Article

References (36)

1. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991;151:933-8.
2. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005;352:1791-8.
3. deVeber G, Andrew M, Adams C, Bjornson B, Booth F, Buckley DJ, et al., Canadian Pediatric Ischemic Stroke Study Group. Cerebral sinovenous thrombosis in children. N Engl J Med. 2001;345:417-23. (Pubitemid 32747605)
4. Martinelli I, Bucciarelli P, Passamonti SM, Battaglioli T, Previtali E, Mannucci PM. Long-term evaluation of the risk of recurrence after cerebral sinus-venous thrombosis. Circulation. 2010;121:2740-6.
5. Ferro JM, Canhaõ P, Stam J, Bousser MG, Barinagarrementeria F, ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35: 664-70. (Pubitemid 38280838)
6. Raizer JJ, DeAngelis LM. Cerebral sinus thrombosis diagnosed by MRI and MR venography in cancer patients. Neurology. 2000;54:1222-6. (Pubitemid 30174037)
7. Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin- gene mutation and in users of oral contraceptives. N Engl J Med. 1998;338:1793-7. (Pubitemid 28277959)
8. Lanska DJ, Kryscio RJ. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke. 2000;31:1274-82. (Pubitemid 30351245)
9. Martinelli I, Battaglioli T, Pedotti P, Cattaneo M, Mannucci PM. Hyperhomocysteinemia in cerebral vein thrombosis. Blood. 2003;102:1363-6. (Pubitemid 36988044)
10. Simchen MJ, Goldstein G, Lubetsky A, Strauss T, Schiff E, Kenet G. Factor v Leiden and antiphospholipid antibodies in either mothers or infants increase the risk for perinatal arterial ischemic stroke. Stroke. 2009;40:65-70.
11. Berkun Y, Padeh S, Barash J, Uziel Y, Harel L, Mukamel M, et al. Antiphospholipid syndrome and recurrent thrombosis in children. Arthritis Rheum. 2006;55:850-5. (Pubitemid 44917456)
12. Kottke-Marchant K, Duncan A. Antithrombin deficiency: issues in laboratory diagnosis. Arch Pathol Lab Med. 2002;126:1326-36. (Pubitemid 36237283)
13. Dahlbäck B. The protein C anticoagulant system: inherited defects as basis for venous thrombosis. Thromb Res. 1995;77:1-43.
14. Beauchamp NJ, Dykes AC, Parikh N, Campbell Tait R, Daly ME. The prevalence of, and molecular defects underlying, inherited protein S deficiency in the general population. Br J Haematol. 2004;125:647-54. (Pubitemid 38747968)
15. Segers K, Dahlbäck B, Nicolaes GA. Coagulation factor V and thrombophilia: background and mechanisms. Thromb Haemost. 2007;98:530-42. (Pubitemid 47412879)
16. Vicente V, González-Conejero R, Rivera J, Corral J. The prothrombin gene variant 20210A in venous and arterial thromboembolism. Haematologica. 1999;84:356-62. (Pubitemid 29474351)
17. Takamiya O, Ishida F, Kodaira H, et al. APC-resistance and Mnl I genotype (Gln 506) of coagulation factor V are rare in Japanese population. Thromb Haemost. 1995;74:996.
18. Miyata T, Kimura R, Kokubo Y, Sakata T. Genetic risk factors for deep vein thrombosis among Japanese: importance of protein S K196E mutation. Int J Hematol. 2006;83:217-23. (Pubitemid 44227995)
19. Mahmoodi BK, Brouwer JL, Ten Kate MK, Lijfering WM, Veeger NJ, Mulder AB, et al. A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin. J Thromb Haemost. 2010;8:1193-200.
20. Kenet G, Lütkhoff LK, Albisetti M, Bernard T, Bonduel M, Brandao L, et al. Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies. Circulation. 2010;121:1838-47.
21. Ikejiri M, Tsuji A, Wada H, Sakamoto Y, Nishioka J, Ota S, et al. Analysis three abnormal Protein S genes in a patient with pulmonary embolism. Thromb Res. 2010;125:529-32.
22. Sas G, Blaskó G, Bánhegyi D, Jákó J, Pálos LA. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia. Thromb Diath Haemorrh. 1974;32:105-15.
23. Takahashi T, Shinohara K, Nawata R, Wakiyama M, Hamasaki N. A novel mutation of the protein C gene with a frameshift deletion of 3 base pair F ((3380)AGG) in exon 6 in type 1 deficiency associated with arterial and venous thrombosis. Am J Hematol. 1999;62:260-1.
24. Hayashi T, Nishioka J, Shigekiyo T, Saito S, Suzuki K. Protein S Tokushima: abnormal molecule with a substitution of Glu for Lys-155 in the second epidermal growth factor-like domain of protein S. Blood. 1994;83:683-90.
25. Hayashi T, Nishioka J, Suzuki K. Molecular mechanism of the dysfunction of protein S(Tokushima) (Lys155 ? Glu) for the regulation of the blood coagulation system. Biochim Biophys Acta. 1995;1272:159-67. (Pubitemid 26009852)
26. Kimura R, Honda S, Kawasaki T, Tsuji H, Madoiwa S, Sakata Y, et al. Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients. Blood. 2006;107:1737-8. (Pubitemid 43242422)
27. Yamazaki T, Sugiura I, et al. A phenotypically neutral dimorphism of protein S: the substitution of Lys155 by Glu in the second EGF domain predicted by an A to G base exchange in the gene. Thromb Res. 1993;70:395-403. (Pubitemid 23171426)
28. Kinoshita S, Iida H, et al. Protein S and protein C gene mutations in Japanese deep vein thrombosis patients. Clin Biochem. 2005;38:908-15. (Pubitemid 41316649)
29. Shindo A, Ikejiri M, Ii Y, Nakatani K, Wada H, Nobori T, et al. A novel protein S gene mutation combined with protein S Tokushima mutation in a patient with superior sagittal sinus thrombosis. J Neurol. 2012;259:178-9.
30. Aibiki M, Fukuoka N, Nishiyama T, Maekawa S, Shirakawa Y. Differences in antithrombin III activities by administration method in critical patients with disseminated intravascular coagulation: a pharmacokinetic study. Shock. 2007;28:141-7. (Pubitemid 47220823)
31. Wada H, Usui M, Sakuragawa N. Hemostatic abnormalities and liver diseases. Semin Thromb Hemost. 2008;34:772-8.
32. Pabinger-Fasching I. Warfarin-reversal: results of a phase III study with pasteurised, nanofiltrated prothrombin complex concentrate. Thromb Res. 2008;122:S19-22. (Pubitemid 351783320)
33. Trigg DE, Wood MG, Kouides PA, Kadir RA. Hormonal influences on hemostasis in women. Semin Thromb Hemost. 2011; 37:77-86.
34. Suzuki A, Sanda N, Miyawaki Y, Fujimori Y, Yamada T, Takagi A, et al. Down-regulation of PROS1 gene expression by 17betaestradiol via estrogen receptor alpha (ERalpha)-Sp1 interaction recruiting receptor- interacting protein 140 and the corepressor- HDAC3 complex. J Biol Chem. 2010;285:13444-53.
35. Tripodi A, de Groot PG, Pengo V. Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment. J Intern Med. 2011;270:110-22.
36. Muscal E, Brey RL. Antiphospholipid syndrome and the brain in pediatric and adult patients. Lupus. 2010;19:406-11.